Anorectic effects of circulating cytokines: Role of the vascular blood-brain barrier

Nutrition

Volumn 17, Issue 5, 2001, Pages 434-437

  Banks, William Allen ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interleukin 1; Interleukin 6; Interleukins; Leptin; Obesity; Transport; Tumor necrosis factor

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PROTEIN P16; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANOREXIA; APPETITE; BLOOD BRAIN BARRIER; BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; ENDOTHELIUM CELL; FEEDING; HUMAN; INTERSTITIAL FLUID; MATURATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN TRANSPORT;

EID: 0035013816     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(01)00507-X     Document Type: Conference Paper

References (39)

1. Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999;20:1341
2. Langhans W, Hrupka B. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 1999;33:415
3. Reichlin S, Chen G, Nicolson M. Blood to brain transfer of leptin in normal and interleukin-lbeta treated male rats. Endocrinology 2000;141:1951
4. Dantzer R. How do cytokines say hello to the brain? Neural versus humoral mediation. Eur Cytokine Netw 1994;5:271
5. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 1995;57:1011
6. Banks WA. Cytokines, CVOs, and the blood-brain barrier. In: Ader R, Feiten DL, Cohen N, eds. Psychoneuroimmunology. San Diego: Academic Press, 2001; 483
7. Deli MA, Descamps L, Dehouck M-P, et al. Exposure of tumor necrosis factor-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 1995;41:717
8. Megyeri P, Abraham CS, Temesvari P, et al. Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992;148:137
9. Male D. The blood-brain barrier - no barrier to a determined lymphocyte. In: Greenwood J, Begley DJ, Segal MB, eds. New concepts of a blood-brain barrier. New York: Plenum Press, 1995:311
10. Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 1998;139:4556
11. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995;2:241
12. Plotkin SR, Banks WA, Maness LM, Kastin AJ. Differential transport of rat and human interleukin-1α across the blood-brain barrier and blood-testis barrier in rats. Brain Res 2000;881:57
13. Maness LM, Banks WA, Zadina JE, Kastin AJ. Selective transport of bloodborne interleukin-1α into the posterior division of the septum of the mouse brain. Brain Res 1995;700:83
14. Guan XM, Hess JF, Yu H, Hey PJ, van der Ploeg LH. Differential expression of mRNA for leptin receptor isoforms in the rat brain. Mol Cell Endocrinol 1997; 133:1
15. Shioda S, Funahashi H, Nakajo S, et al. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci Lett 1998;243:41
16. Banks WA, Clever CM, Farrell CL. Partial saturation and regional variation in the blood to brain transport of leptin in normal weight mice. Am J Physiol 2000;278:E1158
17. Banks WA, Kastin AJ. Editorial review: peptide transport systems for opiates across the blood-brain barrier. A J Physiol 1990;259:E1
18. Banks WA, Kastin AJ, Arimura A. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP. Exp Neurol 1998;151:116
19. Mizushima H, Banks WA, Dohi K, et al. The effect of cardiac arrest on the permeability of the mouse blood-brain and blood-spinal cord barrier to pituitary adenylate cyclase activating polypeptide (PACAP) (abstract). Peptides 1999;20: 1337
20. Banks WA, Kastin AJ. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci 1996;59:1923
21. Banks WA, Kastin AJ, Durham DA. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull 1989;23:433
22. Banks WA, Kastin AJ, Ehrensing CA. Diurnal uptake of circulating interleukin-la by brain, spinal cord, testis and muscle. Neuroimmunomodulation 1998;5:36
23. Pan W, Banks WA, Kastin AJ. BBB permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol 1997; 146:367
24. Pan W, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am J Physiol 1996;271:E636
25. Mizushima H, Banks WA, Dohi K, Shioda S, Matsumoto K. Effect of cardiac arrest on brain weight and the permeability of the blood-brain barrier and blood-spinal cord barrier to albumin and tumor necrosis factor-a. Life Sci 1999;20:2127
26. Kastin AJ, Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier (abstract). Regul Peptides 2000;92:37
27. Hall CD, Snyder CR, Robertson KR, et al. Cerebrospinal fluid analysis in human immunodeficiency virus infection. Ann Clin Lab Sci 1992;22:139
28. Pozzilli C, Bernardi S, Mansi L, et al. Quantitative assessment of the blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J Neurol Neurosurg Psychiatry 1988;51:1058
29. Rapoport SI. Pathological alterations of the blood-brain barrier. In: Blood-brain barrier in physiology and medicine. New York: Raven Press, 1976:129
30. Johansson BB. Hypertension and the blood-brain barrier. In: Neuwelt EA, ed. Implications of the blood-brain barrier and its manipulation. Vol 2: Clinical aspects. New York: Plenum Publishing, 1989:389
31. Greenwood J, Pratt OE. The effect of ethanol upon thiamine transport across the blood-brain barrier in the rat. J Physiol (Lond) 1983;348:61P
32. De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991;325:703
33. Schinkel AH, Smit JJM, van Tellingen O, et al. Disruption of the mouse mdrla p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491
34. Banks WA, Kastin AJ. Brain-to-blood transport of peptides and the alcohol withdrawal syndrome. In: Strand FL, Beckwith B, Chronwall B, Sandman CA, eds. Models of neuropeptide action. New York: New York Academy of Sciences, 1994:739:108
35. Persidsky Y, Stins M, Way D, et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997;158:3499
36. Maness LM, Banks WA, Kastin AJ. Persistence of blood-to brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res 2000;873:165
37. Burguera B, Couce ME, Curran GL, et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 2000;49:1219
38. Nave H, Brabant G, Heckmann A, von Hoersten S, Pabst R. The blood-brain barrier in obesity: immunological and functional evidence of its impairment and of a reduced leptin passage in rodent diet-induced obesity. Soc Neurosci Abstr 2000;26:343
39. Smith QR, Momma S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 1987;49:1651